APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transient Receptor Potential Cation Channel Subfamily V Member 1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2026-2032

Report ID 174042740219 December 2025194 pages

Choose your research edition.

Industry ResearchTransient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Transient Receptor Potential Cation Channel Subfamily V Member 1, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transient Receptor Potential Cation Channel Subfamily V Member 1, also provides the revenue of main regions and countries. Of the upcoming market potential for Transient Receptor Potential Cation Channel Subfamily V Member 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, projected growth trends, production technology, application and end-user industry.

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company

Amgen Inc

Vitality Biopharma Inc

Toray Industries Inc

Sylentis SAU

Pila Pharma AB

Neurim Pharmaceuticals Ltd

Medifron DBT Co Ltd

Kyowa Hakko Kirin Co Ltd

Grunenthal GmbH

Flex Pharma Inc

DoNatur GmbH

Daewoong Pharmaceutical Co Ltd

Centrexion Therapeutics Corp

BCN Peptides SA

Amorepacific Corp

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107

CMX-020

CA-016

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain

Muscle Spasm

Immunology

Pruritus

Ophthalmology

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transient Receptor Potential Cation Channel Subfamily V Member 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transient Receptor Potential Cation Channel Subfamily V Member 1 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DD-04107 Major Player Table 3. CMX-020 Major Player Table 4. CA-016 Major Player Table 5. Others Major Player Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Abdominal Pain Major Player Table 8. Muscle Spasm Major Player Table 9. Immunology Major Player Table 10. Pruritus Major Player Table 11. Ophthalmology Major Player Table 12. Others Major Player Table 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends Table 14. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers Table 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges Table 16. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints Table 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2021-2026) Table 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2027-2032) Table 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2021-2026) Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Headquarters & Area Served Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application Table 27. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2026) Table 34. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2027-2032) Table 35. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2026) Table 39. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2027-2032) Table 40. Amgen Inc Company Information Table 41. Amgen Inc Business Overview Table 42. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 44. Amgen Inc Recent Development Table 45. Vitality Biopharma Inc Company Information Table 46. Vitality Biopharma Inc Business Overview Table 47. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 49. Vitality Biopharma Inc Recent Development Table 50. Toray Industries Inc Company Information Table 51. Toray Industries Inc Business Overview Table 52. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 54. Toray Industries Inc Recent Development Table 55. Sylentis SAU Company Information Table 56. Sylentis SAU Business Overview Table 57. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 59. Sylentis SAU Recent Development Table 60. Pila Pharma AB Company Information Table 61. Pila Pharma AB Business Overview Table 62. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 64. Pila Pharma AB Recent Development Table 65. Neurim Pharmaceuticals Ltd Company Information Table 66. Neurim Pharmaceuticals Ltd Business Overview Table 67. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 69. Neurim Pharmaceuticals Ltd Recent Development Table 70. Medifron DBT Co Ltd Company Information Table 71. Medifron DBT Co Ltd Business Overview Table 72. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 74. Medifron DBT Co Ltd Recent Development Table 75. Kyowa Hakko Kirin Co Ltd Company Information Table 76. Kyowa Hakko Kirin Co Ltd Business Overview Table 77. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 79. Kyowa Hakko Kirin Co Ltd Recent Development Table 80. Grunenthal GmbH Company Information Table 81. Grunenthal GmbH Business Overview Table 82. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 84. Grunenthal GmbH Recent Development Table 85. Flex Pharma Inc Company Information Table 86. Flex Pharma Inc Business Overview Table 87. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 89. Flex Pharma Inc Recent Development Table 90. DoNatur GmbH Company Information Table 91. DoNatur GmbH Business Overview Table 92. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 94. DoNatur GmbH Recent Development Table 95. Daewoong Pharmaceutical Co Ltd Company Information Table 96. Daewoong Pharmaceutical Co Ltd Business Overview Table 97. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 99. Daewoong Pharmaceutical Co Ltd Recent Development Table 100. Centrexion Therapeutics Corp Company Information Table 101. Centrexion Therapeutics Corp Business Overview Table 102. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 104. Centrexion Therapeutics Corp Recent Development Table 105. BCN Peptides SA Company Information Table 106. BCN Peptides SA Business Overview Table 107. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 109. BCN Peptides SA Recent Development Table 110. Amorepacific Corp Company Information Table 111. Amorepacific Corp Business Overview Table 112. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 114. Amorepacific Corp Recent Development Table 115. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (US$ Million) & (2027-2032) Table 122. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (US$ Million) Table 128. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (US$ Million) & (2027-2032) Table 129. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 130. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 131. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 132. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (US$ Million) & (2021-2026) Table 139. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Region (US$ Million) & (2027-2032) Table 140. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026) & (US$ Million) Table 141. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032) & (US$ Million) Table 142. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026) & (US$ Million) Table 143. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032) & (US$ Million) Table 144. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026) & (US$ Million) Table 146. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (US$ Million) & (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Image Figure 2. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. DD-04107 Image Figure 5. CMX-020 Image Figure 6. CA-016 Image Figure 7. Others Image Figure 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Abdominal Pain Image Figure 11. Muscle Spasm Image Figure 12. Immunology Image Figure 13. Pruritus Image Figure 14. Ophthalmology Image Figure 15. Others Image Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million) & (2021-2032) Figure 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2032) Figure 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2032) Figure 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032) Figure 29. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032) Figure 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2021-2032) Figure 31. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032) Figure 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032) Figure 37. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2021-2032) Figure 38. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032) Figure 48. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032) Figure 49. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032) Figure 51. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032) Figure 52. Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Region (2021-2032) Figure 53. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032) Figure 61. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032) Figure 62. SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Country (2021-2032) Figure 63. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • DD-04107
  • CMX-020
  • CA-016
  • Others
Applications
  • Abdominal Pain
  • Muscle Spasm
  • Immunology
  • Pruritus
  • Ophthalmology
  • Others
Companies covered
  • Amgen Inc
  • Vitality Biopharma Inc
  • Toray Industries Inc
  • Sylentis SAU
  • Pila Pharma AB
  • Neurim Pharmaceuticals Ltd
  • Medifron DBT Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Grunenthal GmbH
  • Flex Pharma Inc
  • DoNatur GmbH
  • Daewoong Pharmaceutical Co Ltd
  • Centrexion Therapeutics Corp
  • BCN Peptides SA
  • Amorepacific Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Type
  3. 1.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DD-04107
  5. 1.2.3 CMX-020
  6. 1.2.4 CA-016
  7. 1.2.5 Others
  8. 1.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Application
  9. 1.3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Abdominal Pain
  11. 1.3.3 Muscle Spasm
  12. 1.3.4 Immunology
  13. 1.3.5 Pruritus
  14. 1.3.6 Ophthalmology
  15. 1.3.7 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
  1. 2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
  2. 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
  3. 2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
  4. 2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2021-2032)
  2. 3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
  3. 3.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026)
  5. 3.2.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players
  2. 4.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2021-2026)
  3. 4.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Headquarters & Area Served
  7. 4.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application
  8. 4.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
  11. 4.6.3 2025 Transient Receptor Potential Cation Channel Subfamily V Member 1 Tier 1, Tier 2, and Tier 3
5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
  1. 5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 5.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2032)
6 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
  1. 6.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  3. 6.3 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Amgen Inc
  2. 7.1.1 Amgen Inc Company Information
  3. 7.1.2 Amgen Inc Business Overview
  4. 7.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  6. 7.1.5 Amgen Inc Recent Developments
  7. 7.2 Vitality Biopharma Inc
  8. 7.2.1 Vitality Biopharma Inc Company Information
  9. 7.2.2 Vitality Biopharma Inc Business Overview
  10. 7.2.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  12. 7.2.5 Vitality Biopharma Inc Recent Developments
  13. 7.3 Toray Industries Inc
  14. 7.3.1 Toray Industries Inc Company Information
  15. 7.3.2 Toray Industries Inc Business Overview
  16. 7.3.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  18. 7.3.5 Toray Industries Inc Recent Developments
  19. 7.4 Sylentis SAU
  20. 7.4.1 Sylentis SAU Company Information
  21. 7.4.2 Sylentis SAU Business Overview
  22. 7.4.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  24. 7.4.5 Sylentis SAU Recent Developments
  25. 7.5 Pila Pharma AB
  26. 7.5.1 Pila Pharma AB Company Information
  27. 7.5.2 Pila Pharma AB Business Overview
  28. 7.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  30. 7.5.5 Pila Pharma AB Recent Developments
  31. 7.6 Neurim Pharmaceuticals Ltd
  32. 7.6.1 Neurim Pharmaceuticals Ltd Company Information
  33. 7.6.2 Neurim Pharmaceuticals Ltd Business Overview
  34. 7.6.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  36. 7.6.5 Neurim Pharmaceuticals Ltd Recent Developments
  37. 7.7 Medifron DBT Co Ltd
  38. 7.7.1 Medifron DBT Co Ltd Company Information
  39. 7.7.2 Medifron DBT Co Ltd Business Overview
  40. 7.7.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  42. 7.7.5 Medifron DBT Co Ltd Recent Developments
  43. 7.8 Kyowa Hakko Kirin Co Ltd
  44. 7.8.1 Kyowa Hakko Kirin Co Ltd Company Information
  45. 7.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
  46. 7.8.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  48. 7.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  49. 7.9 Grunenthal GmbH
  50. 7.9.1 Grunenthal GmbH Company Information
  51. 7.9.2 Grunenthal GmbH Business Overview
  52. 7.9.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  54. 7.9.5 Grunenthal GmbH Recent Developments
  55. 7.10 Flex Pharma Inc
  56. 7.10.1 Flex Pharma Inc Company Information
  57. 7.10.2 Flex Pharma Inc Business Overview
  58. 7.10.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  60. 7.10.5 Flex Pharma Inc Recent Developments
  61. 7.11 DoNatur GmbH
  62. 7.11.1 DoNatur GmbH Company Information
  63. 7.11.2 DoNatur GmbH Business Overview
  64. 7.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  66. 7.11.5 DoNatur GmbH Recent Developments
  67. 7.12 Daewoong Pharmaceutical Co Ltd
  68. 7.12.1 Daewoong Pharmaceutical Co Ltd Company Information
  69. 7.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
  70. 7.12.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  72. 7.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  73. 7.13 Centrexion Therapeutics Corp
  74. 7.13.1 Centrexion Therapeutics Corp Company Information
  75. 7.13.2 Centrexion Therapeutics Corp Business Overview
  76. 7.13.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  78. 7.13.5 Centrexion Therapeutics Corp Recent Developments
  79. 7.14 BCN Peptides SA
  80. 7.14.1 BCN Peptides SA Company Information
  81. 7.14.2 BCN Peptides SA Business Overview
  82. 7.14.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  84. 7.14.5 BCN Peptides SA Recent Developments
  85. 7.15 Amorepacific Corp
  86. 7.15.1 Amorepacific Corp Company Information
  87. 7.15.2 Amorepacific Corp Business Overview
  88. 7.15.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  90. 7.15.5 Amorepacific Corp Recent Developments
8 North America
  1. 8.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2032)
  2. 8.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 8.2.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026)
  4. 8.2.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032)
  5. 8.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032)
  6. 8.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  7. 8.4.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026)
  8. 8.4.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032)
  9. 8.5 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032)
  10. 8.6 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
  11. 8.6.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026)
  13. 8.6.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2032)
  2. 9.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032)
  5. 9.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032)
  9. 9.5 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
  11. 9.6.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2032)
  2. 10.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 10.2.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026)
  4. 10.2.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032)
  5. 10.3 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032)
  6. 10.4 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  7. 10.4.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026)
  8. 10.4.2 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032)
  9. 10.5 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2032)
  2. 11.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032)
  5. 11.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032)
  9. 11.5 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
  11. 11.6.1 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue (2021-2032)
  2. 12.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country
  11. 12.6.1 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst